Figures 1B and C show the expression levels of DNMT3B in nontumour and in tumour samples of the TCGA–BRCA dataset, in the total cohort, and in different molecular subtypes: luminal-A, luminal-B, HER2-enriched, and basal-like. This evidence concerns the gene ERBB2 and neoplasm.